1Van Zwieten PA.Pharmacologic profile of urapidil. Am J Cardiol, 1989,64(7):1D.
2Prichard BN, Renondin JC, Tomlinson B. Clinical pharmacology of urapidil.Journal Hypertension Suppl, 1988,6(2):S13.
3Prichard BN, Tomlinson B, Renodin JC.Urapidil a multipleaction alpha-blocking drug. Am J Cardiol, 1989,64(7):11D
4De Leeuw PW, Van ES PN, De bruyg HA, et al. Renal hamodynamic and neurohumoral response to urapidil in hypertensive man. Drugs,1989,35 Suppl 6:74-79.
5Tubb U, Wurst W, Nwuhaus KL, et al.Acute hamodynamic effects of urapidil in patients with chronic lert ventricular failure. Eur J Clin Pharmacol, 1988,35 (1):305-308.
6Bielen E, Fagard R, Slaessen J, et al.Urapidil induced hemodynamic changes in humans. Am J Cardiol,1989,64(7):16D.
7Molloff T, Van Aken H, Mulier JP, et al.Effects of urapidil ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary bypass grafting. Br J Anaesthesia, 1990,64(4):493-496.
